 In this video, we're going to go through the top three robotics penny stocks. We're going to focus in the robotics industry here, another emerging industry. And I think as this industry grows in robotics, we're going to see a lot of these stocks move up a lot. They already have been a lot, but I think there is a lot more room to run in some of these penny stocks that we'll talk about today in this video. I've got to say, I'm not a financial advisor. I'm a business teacher in my daily life, but I'm buying new means and expert on the stock market. You don't also have to bear in mind, obviously, penny stocks are very volatile, but we'll go into the information in this video that I've got for you right now. If you could leave a like on the video, that would be fantastic. It helps it out, get it up into that YouTube search result. So any support is greatly appreciated. So the first stock we're talking about is TransEntrix. And this is a very, very interesting one indeed. So this is in terms of a surgery robotic system. So they can do surgery through this robotic system. OK, it has sort of a bit of an AI component to it as well and a data analytics component to it. But it's a robotic system that can basically perform surgery. And ultimately, the aim of this is to improve the surgical experience in ways that matter. So they've developed this system and it's doing really well in terms of people. It's getting a lot of attention now. A lot of people are invested in this. And I do think it's got a lot more to run on this stock, even though it has run up a lot. I do think it's going to go further. I mean, if you look into the information on this stock, I really do really encourage anyone to do their due diligence on this one. And you'll really see the real strong potential in the longer term for this stock, or at least medium long, right? Let's go through this further. Now, there's been some recent news here. So on February 10th, they are actually hosting a virtual investor day on the February 23rd. OK, so it says, a medical device company that is digitizing the interface between the surgeon and their patient to improve minimally invasive surgery. Today announced it will host a virtual investor day. OK, and it says here, we are excited to provide an update on Senhance, including a deep dive into the technology and how we are positioning our system. OK, so this is a very interesting penny stock. I think it's got a lot of potential. And also you've got this other recent, fairly recent news is that they had a bought deal for seventy nine point six million bought deal offering. And this was actually at three dollars per share. So this is incredible considering when we first covered this, we'll go through the price, right? There's now a bought deal for three dollars a share for seventy seventy nine point six million here. Interesting, interesting stuff. Now, you'll notice here that we actually covered this stock. This was actually covered about four weeks ago and we covered it first when it was at zero point eight five. OK, so where is it sat now? It sat four dollars fifty eight and so it has had this run up. OK, but I do think that this is potentially going to go to above ten dollars. I really believe that TRXC is going to go above ten dollars. So I think it's got a lot of potential. I think that obviously there is now more downside because of the run up. But again, I do say like I said, I think it's going to go much further than the four dollars fifty eight, especially now you've had the recent news coming out about like it's bought deal offering at three dollars. So if it does fall back, maybe it'll fall back to around three dollars, three dollars, twenty, maybe two around that kind of range. And, you know, maybe it'll do that. But maybe it'll just keep running. It'll keep running towards the ten dollars and get towards that level there. OK, it's got a market cap of six hundred thirty eight million. And it's just it keeps running. It's an unbelievable stock, this and the movements that it's been making. And rightfully so, because it seems like a really good company and they've got a really good product. OK, so that's what it's based upon, the fundamentals as to why it's actually moving up. OK, and I do think it's got a lot of potential. The recent issue as well was with the cash burn. They were kind of running out of cash at one point when I was covering it. I was running out of cash, but now they've actually raised a lot of capital and they've also got a lot of investor sentiment in the stock. Now, they've got that cash now and then they've got what they're doing is they've got the system, they've got this enhanced system, they've developed it, they've, you know, put this together. And now it's about commercializing it, getting this sales moving on this particular stock. And and that's what it's all about. And now they're in a good cash position, it seems at the moment. So that's that's another good positive. You can't look at it from when it was at zero point eight, you know, because it's a different position that it's in now. There's a lot of news that's come out that's been positive. And there's also the fact that they're in a better cash position potentially, right? So this one's a big one. I've also got to say we've actually finally reached 10,000 subscribers. So thank you for all the. Support on the channel, any support you've been offering, whether it's liking the video, subscribing, helping to get into that YouTube search rules, honestly, a like on the video simply just gets up and see YouTube search results. And that really does help out the channel. So any help from just doing that simple, you know, gesture is really much appreciated, right? So that's growing the channel massively just by liking the video. So thank you for all the support on the channel and anything you've been offering. Ten thousand subscribers, an incredible amount. I am potentially setting up either a Patreon or using the YouTube join feature on YouTube. I'm more swaying towards YouTube join feature. We'll see what we do. OK, but maybe I'll do something like that. But thanks for all the support on the channel. The next one we're talking about today is called ReWalk Robotics. ReWalk Robotics. So they've got this kind of exer... sort of exersuit for stroke rehabilitation and also for other issues as well. So sort of a robotics stock in this sense. And it's a very, very interesting one. And I think that there's a lot of applications that could be used for these exersuit. This doesn't come without its competition, though. There is other companies out there that are similar to this that do similar stuff in terms of exersuits. But I think that this one is good in a good position. I really like the branding as well in terms of ReWalk, right? Helping people to sort of find the feet again, so to speak, right? And it's kind of ReWalk Robotics, right? I quite like it. The branding of the company. I like the mission, I like the vision, I like the leadership, I like the objectives of the company. I think this one's really good. I think this one's just going to keep running. You've had this recent news out as well. It's actually paid out any extended credit line. So it paid out outstanding balance on the CREOS credit line. So they've now paid it off, okay? So it's entered into an agreement to establish a line of credit at the end of 2015 and ReWalk drew down an additional tranche of $12 million at the beginning of 2016. And then they've actually started to essentially paid it off, right? So that tells me that they have got some sound finances that they're able to actually pay this off. And they're really taking the finance responsibilities really important and actually taking it seriously, right? And then again, I'm not going through all the information in this video, right? In terms of going to break it down in depth because it's just a top list. So carrying on. What we covered this $1.83, okay? This was on January 13th around that time. And my suggestion was that the penny stock could double fast. 18th, was it 13th of January, could double fast? Well, what is it now? It's that $3.62, it's doubled. And I would say in a month, I would say that's fairly fast, okay? So there we go, $3.62, but you're like, okay, well, yeah, that's great, fantastic. But what do I do now? What's the process now? What should we look at doing? Well, first of all, I'm not a financial advisor, so you obviously decide what you want to do. But I'm holding this one. I'm holding what I've got on this stock. I like the stock. I'm considering to increase a position on this. It's got a lower market cap as well, actually. Interesting, it's got more of a chance to run up. I'm holding this stock. I'm holding my position. I may buy a bit more on a dip, okay? That's what I'm doing, so I'm holding. So what do I think? I think that this is gonna get to sort of $5, okay? I think it's gonna get to $5 easily. So I do think it's got room to run even further. And I think it's a very interesting company. Obviously you do your own research to then you can make your own informed decision on what you want to do with that. But that's one of them. And the next one we've got is Titan Medical. So we've talked about this one fairly recently. Again, this is another robotics surgery player, right? They've got a robotic system that can be used within surgery, okay? And this is Titan Medical. And Titan Medical here is actually announcing its financial results on February 22nd here. So the year end 2020 financial results on February 22nd, 2021, which could potentially be a bit of a run-up before that report, okay? Could be a little bit of a run-up before the report. So that could be a potential fever swing trade or potentially just holding it medium to long. It is an interesting company. I do like the company. I'm holding this medium. I'm not sure long yet. I need to see some more information on these. I'm holding transcentric probably medium long. I'm holding rework medium long and this one's medium at the minute. So when I say medium, I'm talking maybe six to eight months, maybe. Long is like, well, over a year, two year, three year, four years, you know, just long, long, long time, right? We covered this. So you saw the price there. We actually covered this at $54, right? And I think this stock's got the potential to easily move up to like $4, $5. And that's when we covered that on February 2nd. So even just from then, it's moved up to $3.23. I think it's got much more time to run. It's got much more room to run towards that $4, $5 range. So again, this is another stock that's got really good potential here. So essentially all these penny stocks, I mean, in the long term, I mean, in the medium term, I think that this has got room to run to five. But I think even in the long term, a lot of these penny stocks in this robotic sector, they could 5X very easily, if not more, much more. And so I'm just very kind of like these stocks, right? I like this industry. I like the robotics industry. It's an emerging industry, particularly in medical because there's a lot of applications for it. You know, because in terms of helping this, you know, stroke, people suffering from a stroke in terms of reward robotics, you've got these, then you've got these two surgery kind of robotics players. I think it's like a nice combination of those three. So that's what I've got for you in the video. If you found this useful or interesting anywhere, then do leave a like on the video to help you get it up into YouTube search results. And thank you everybody again for all the support. And as I say, I may create a YouTube join feature which you will get some extra perks for or Patreon I haven't decided yet. Again, I could have done this like a few weeks ago. I just, I don't need to necessarily do that but people want me to make it. So I'm considering doing it. Okay, so thanks for all the support and we'll see everybody in the next one.